Robotic Genome Doctrine Accountability

Introduction

The Robotic Genome Doctrine Accountability refers to a proposed legal and ethical framework that determines responsibility for the actions, decisions, and consequences of robotic systems used in genomic research, genetic testing, and genome editing.

Modern biotechnology increasingly combines robotics, artificial intelligence (AI), and genetic engineering to analyse DNA, identify hereditary diseases, and modify genetic material. Although these technologies offer significant benefits in medicine and scientific research, they also create risks involving inaccurate genetic analysis, unintended mutations, privacy violations, and unauthorised genetic modification.

The doctrine seeks to ensure that the use of robotic genomic technology does not create a legal accountability gap. Its fundamental principle is that the use of autonomous technology cannot automatically exempt developers, manufacturers, researchers, healthcare professionals, or institutions from legal responsibility.

Important Case Laws

1. Gene Campaign v. Union of India (2024), 2024 INSC 545

The Supreme Court examined the regulatory approval of genetically modified mustard, DMH-11. The Court recognised that regulatory decisions concerning genetically modified organisms are subject to judicial review. It directed the Union Government to formulate a national policy on GM crops through consultation with relevant stakeholders and emphasised verification of expert credentials and disclosure of conflicts of interest.

Indian Kanoon+1

This case provides a significant foundation for robotic genome accountability by emphasising scientific transparency, biosafety, public participation, and regulatory responsibility. It does not directly decide liability for robotic genome editing.

2. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017), (2017) 10 SCC 1

The Supreme Court recognised privacy as a fundamental right under Article 21 and other constitutional freedoms.

Genomic information can reveal hereditary diseases, biological relationships, and sensitive personal characteristics. This judgment supports the protection of genetic data against unlawful collection, disclosure, and misuse by automated genomic systems.

3. Selvi v. State of Karnataka (2010), (2010) 7 SCC 263

The Supreme Court held that involuntary narcoanalysis, polygraph examinations, and brain electrical activation profile tests violate constitutional protections under Articles 20(3) and 21.

The judgment supports personal autonomy and protection against compelled scientific investigation. Its relevance to robotic genomic testing is analogous; it does not establish a direct prohibition on DNA testing or genome editing.

4. Anil @ Anthony Arikswamy Joseph v. State of Maharashtra (2014), (2014) 4 SCC 69

The Supreme Court discussed the evidentiary value of DNA profiling and emphasised that its reliability depends upon laboratory quality control and proper scientific procedures.

National Digital Library of India+1

This case is relevant to robotic genome accountability because automated genomic systems must produce scientifically reliable results. Errors arising from defective equipment, contamination, improper sample handling, or unreliable algorithms may undermine the evidentiary value of genomic analysis.

5. Bhabani Prasad Jena v. Orissa State Commission for Women (2010), (2010) 8 SCC 633

The Supreme Court held that DNA testing should not be ordered routinely in parentage disputes. Courts must consider the necessity of the test and its consequences for privacy, dignity, and family relationships.

Indian Kanoon+1

This judgment supports the principle that robotic genomic testing must have a legitimate purpose and appropriate legal justification.

Legal Framework in India

India does not formally recognise a standalone statute titled the Robotic Genome Doctrine Accountability. Its principles are derived from existing legislation and regulatory mechanisms.

Environment (Protection) Act, 1986: Provides the statutory foundation for regulating specified genetically engineered organisms.

1989 Biosafety Rules: Establish regulatory controls over specified research, manufacture, use, and environmental release of genetically engineered organisms.

Digital Personal Data Protection Act, 2023: Relevant to digital genomic information, subject to applicable provisions and commencement.

Consumer Protection Act, 2019: May provide remedies for defective genomic devices and deficient services.

Articles 14 and 21: Support fairness, privacy, dignity, and protection of life and personal liberty.

India's biosafety framework also involves the Institutional Biosafety Committee and Review Committee on Genetic Manipulation. Gene-editing therapies may additionally be subject to drug and clinical-trial regulation.

Press Information Bureau+1

Core Principles of Accountability

Developer responsibility: Developers should be accountable for negligent algorithm design, inadequate validation, and foreseeable software failures.

Manufacturer liability: Manufacturers must ensure the safety and reliability of robotic genomic equipment.

Professional accountability: Healthcare professionals and researchers must exercise independent judgment rather than blindly relying on automated results.

Institutional governance: Laboratories and hospitals should maintain audit records, quality-control systems, and secure genomic databases.

Informed consent: Individuals should understand the purpose, risks, and potential consequences of genomic procedures.

Human supervision: High-risk genome-editing procedures should remain under qualified human oversight.

Effective remedies: Individuals harmed by negligent genomic procedures should have access to appropriate legal remedies.

Conclusion

The Robotic Genome Doctrine Accountability represents an emerging legal framework for determining responsibility in robotic genomic research, genetic testing, and genome editing. Although Indian law does not formally establish this doctrine as an independent legal principle, constitutional jurisprudence, biosafety regulation, and judicial decisions provide its foundation.

The judgments in Gene Campaign, Puttaswamy, Selvi, Anil @ Anthony Arikswamy Joseph, and Bhabani Prasad Jena establish important principles concerning regulatory transparency, privacy, scientific reliability, and individual autonomy.

A comprehensive legal framework should ensure that robotic genomic technologies remain subject to human supervision, transparent regulation, and effective legal remedies. The ultimate objective is to promote scientific innovation while protecting human dignity, genetic privacy, biological safety, and the interests of future generations.